ESTRO 36 Programme book and exhibition guide

L. Sommers (The Netherlands), R. Steenbakkers, H. Bijl, J. Vemer-van den Hoek, J. Roodenburg, S. Oosting, S. De Rooij, J. Langendijk > Significance of mutant p53 and Ki67 as predictive biomarkers post Chemo-RT in locally advanced HNSCC P. Baskaran Shanmuga (India), K. Periasamy, S. Sharma, G.K. Singh, K. Pratap, P. Singh, V. Yadav, A.K. Mandal, K.T. Bhowmik > Dose-volume analysis of the hypoglossal nerve and its correlation with Dysarthria-Dysphagia Syndrome F. Chen (China), R. Ren > 18F-FDG-PET in guiding dose-painting with IMRT in oropharyngeal tumours (FiGaRO) – swallow qesults C. Doughty (UK), J. Dunton, A. Michaelidou, M. Lei, T. Guerrero Urbano > Chronic radiation-associated dysphagia (RAD) after curative reirradiation in head and neck cancer L. Gutierrez Bayard (Spain), M. Salas Buzón, E. Porras Alonso, S. Garduño Sánchez, M. Macias, L. Ingunza Barón, E. Gonzalez Calvo, I. Villanego Beltran, V. Diaz Diaz > Intraoperative electron beam radiotherapy for locoregionally recurrent head and neck cancer P. Wald (USA), J. Grecula, A. Bhatt, V. Diavolitsis, T. Teknos, M. Old, J. Rocco, A. Agarwal, E. Ozer, R. Carrau, D. Blakaj > CTV growth evaluation for involved site neck lymphoma RT if pre- chemo RT position PET-CT is absent D. Bird (UK), C. Patel, A. Scarsbrook, V. Cosgrove, E. Thomas, D. Gilson, R. Prestwich > Identifying risk factors for L’Hermitte’s syndrome after chemo-IMRT for head and neck cancer H. Laidley (UK), D. Noble, G. Barnett, R. Jena, N. Burnet > The preliminary report of PG2 in improving QoL of pharyngeal cancer patients in chemoradiotherapy H.M. Wang (Taiwan), J.R. Lin, C.H. Hsieh, C.L. Hsu, C.Y. Lin, J.T.C. Chang > Olfactory neuroblastoma – 10-year experience with VMAT radiotherapy H. Ariyaratne (UK), A. Ward, P. Bhudia, V. Lund, D. Carnell

EP-1033

ELECTRONIC POSTERS

EP-1034

EP-1035

EP-1036

EP-1037

EP-1038

EP-1039

EP-1040

EP-1041

EP-1042

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

222